a r&d company for the treatment of allergic rhinitis and other chronic respiratory diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, VRNA has been loosely correlated with KRYS. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if VRNA jumps, then KRYS could also see price increases.
Ticker / NAME | Correlation To VRNA | 1D Price Change % | ||
---|---|---|---|---|
VRNA | 100% | -5.31% | ||
KRYS - VRNA | 35% Loosely correlated | -1.60% | ||
AKBA - VRNA | 35% Loosely correlated | -1.54% | ||
ARQT - VRNA | 34% Loosely correlated | +2.15% | ||
INZY - VRNA | 33% Loosely correlated | -5.59% | ||
PLRX - VRNA | 33% Loosely correlated | -0.36% | ||
More |
Ticker / NAME | Correlation To VRNA | 1D Price Change % |
---|---|---|
VRNA | 100% | -5.31% |
allergic theme (4 stocks) | 77% Closely correlated | -3.13% |
drugs theme (254 stocks) | 40% Loosely correlated | -0.52% |
pharmaceuticals theme (159 stocks) | 40% Loosely correlated | -1.10% |
treatment theme (56 stocks) | 38% Loosely correlated | +0.23% |
diseases theme (41 stocks) | 38% Loosely correlated | -0.05% |
More |